Latest filing published 25 Sept 2026 for Phio Pharmaceuticals Corp., €5,783.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Patricia A. Bradford is a declared insider of Phio Pharmaceuticals Corp., with filings sourced from SEC (Form 4). In total, 7 filings cover trades dated from 9 August 2022 to 24 September 2026.
Every open-market trade on record is a purchase: 2 purchases worth €16k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants. So far in 2026, the count stands at 2 purchases and no sales.
Most recently, on 25 September 2026, the filings show an open-market purchase worth €5,783 in Phio Pharmaceuticals Corp. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations